Wellnex Life Ltd (ASX: WNX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Wellnex Life Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $25.01 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.25 billion
Earnings per share -0.036
Dividend per share N/A
Year To Date Return 8.70%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Wellnex Life Ltd (ASX: WNX)
    Latest News

    a woman
    Share Fallers

    Bubs Australia Ltd (ASX:BUB) shares sink 12% lower: Time to invest?

    Is the Bubs Australia Ltd (ASX:BUB) share price in the buy zone after its sharp decline?

    Read more »

    a woman
    Share Gainers

    These 3 ASX small caps are pushing higher today

    The Bubs Australia Ltd (ASX:BUB) share price is one of three in the small cap space pushing higher on Tuesday.…

    Read more »

    a woman
    Share Fallers

    Infant formula companies sink lower on new Chinese e-commerce laws

    The Bellamy's Australia Ltd (ASX:BAL) share price and many of its infant formula rivals have sunk lower today after China…

    Read more »

    a woman
    Share Gainers

    These 3 small cap shares are racing higher today

    The Wattle Health Australia Ltd (ASX:WHA) share price is one of three in the small cap space racing higher on…

    Read more »

    a woman
    Share Gainers

    Why these 4 ASX shares have climbed higher today

    The Wattle Health Australia Ltd (ASX:WHA) share price is one of four climbing higher on Wednesday. Here's why...

    Read more »

    a woman
    Share Gainers

    Why Wattle Health Australia Ltd (ASX:WHA) shares stormed higher today

    The Wattle Health Australia Ltd (ASX:WHA) share price stormed higher today. Should you invest?

    Read more »

    a woman
    Growth Shares

    UBS maintains support for A2 Milk Company Ltd (ASX:A2M)

    Formula prices are falling in China, but UBS analysts are optimistic about the outlook for A2 Milk Company Ltd (ASX:A2M)

    Read more »

    a woman
    Retail Shares

    Why this top broker still backs Bellamy's Australia Ltd (ASX:BAL)

    Citibank remains upbeat on the growth prospects of Bellamy’s Australia Ltd (ASX: BAL) despite a short-term earnings hit

    Read more »

    a woman
    Share Gainers

    Why Wattle Health Australia Ltd (ASX:WHA) shares pushed higher today

    The Wattle Health Australia Ltd (ASX:WHA) share price pushed notably higher this morning. Here's what you need to know...

    Read more »

    a woman
    ⏸️ Investing

    Why the Wattle Health Australia Ltd (ASX:WHA) share price is on fire today

    The Wattle Health Australia Ltd (ASX:WHA) share price has been on fire on Friday. Here’s why…

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares are sinking lower today

    The Wattle Health Australia Ltd (ASX:WHA) share price is one of four sinking lower on Tuesday. Here's what you need…

    Read more »

    a woman
    ⏸️ Investing

    Wattle Health Australia Ltd (ASX:WHA) shares are down 33% in a month

    The Wattle Health Australia Ltd (ASX:WHA) share price has fallen 33% in a month. Is it time to invest?

    Read more »

    WNX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Wellnex Life Ltd

    Wellnex Life Ltd is a health and wellness company which is engaged in developing health and wellness products. It offers products including nutritional food products, natural baby skincare range, and nutritional health supplement range. The company offers its products through brands such as The Iron Company, Mr Bright, Nighty Night and others.

    WNX Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    15 Apr 2024 $0.03 $0.00 0.00% 874,863 $0.03 $0.03 $0.02
    12 Apr 2024 $0.02 $0.00 0.00% 4,733,306 $0.02 $0.03 $0.02
    11 Apr 2024 $0.02 $0.00 0.00% 1,182,753 $0.02 $0.03 $0.02
    10 Apr 2024 $0.02 $0.00 0.00% 1,000,646 $0.03 $0.03 $0.02
    09 Apr 2024 $0.03 $0.00 0.00% 569,269 $0.03 $0.03 $0.03
    08 Apr 2024 $0.03 $0.00 0.00% 303,401 $0.03 $0.03 $0.03
    05 Apr 2024 $0.03 $0.00 0.00% 200,001 $0.03 $0.03 $0.03
    04 Apr 2024 $0.03 $0.00 0.00% 639,269 $0.03 $0.03 $0.03
    03 Apr 2024 $0.03 $0.00 0.00% 467,238 $0.03 $0.03 $0.03
    02 Apr 2024 $0.03 $0.00 0.00% 234,391 $0.03 $0.03 $0.03
    28 Mar 2024 $0.03 $0.00 0.00% 174,478 $0.03 $0.03 $0.03
    27 Mar 2024 $0.03 $0.00 0.00% 1,263,136 $0.03 $0.03 $0.03
    26 Mar 2024 $0.03 $0.00 0.00% 395,700 $0.03 $0.03 $0.03
    25 Mar 2024 $0.03 $0.00 0.00% 1,296,336 $0.03 $0.03 $0.03
    22 Mar 2024 $0.03 $0.00 0.00% 819,496 $0.03 $0.03 $0.03
    21 Mar 2024 $0.03 $0.00 0.00% 265,960 $0.03 $0.03 $0.03
    20 Mar 2024 $0.03 $0.00 0.00% 1,187,973 $0.03 $0.03 $0.02
    19 Mar 2024 $0.02 $0.00 0.00% 559,746 $0.03 $0.03 $0.02

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    14 Dec 2023 Eric Jiang Issued 178,572 $5,000
    Rights issue.
    14 Dec 2023 Eric Jiang Issued 59,524 $3,154
    Rights issue.
    14 Dec 2023 George Karafotias Issued 2,285,713 $64,000
    Rights issue.
    14 Dec 2023 George Karafotias Issued 761,905 $40,380
    Rights issue.
    14 Dec 2023 Zheng (Kobe) Li Issued 25,000 $1,325
    Rights issue.
    14 Dec 2023 Zheng (Kobe) Li Issued 75,000 $2,100
    Rights issue.
    14 Dec 2023 Zlatko (Zack) Bozinovski Issued 10,392,857 $290,999
    Rights issue.
    14 Dec 2023 Zlatko (Zack) Bozinovski Issued 3,880,953 $205,690
    Rights issue.
    14 Dec 2023 Zlatko (Zack) Bozinovski Issued 1,250,000 $35,000
    Rights issue.
    02 Nov 2023 Zlatko (Zack) Bozinovski Expiry 2 $0
    Options expired.
    28 Jul 2023 Zlatko (Zack) Bozinovski Issued 1,351,500 $67,575
    Rights issue.
    28 Jul 2023 Zheng (Kobe) Li Issued 175,000 $8,750
    Rights issue.
    28 Jul 2023 George Karafotias Issued 250,000 $12,500
    Rights issue.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Eric Jiang Non-Executive Director Sep 2016
    Mr Jiang has over 15 years' experience and is an adviser to companies involved in trade between Australia and China. Eric brings a distinctive understanding of the cultural, economic and strategic context in which Australian businesses engage with China.
    Mr George Karafotias Chief Financial OfficerExecutive Director Nov 2020
    Mr Karafotias has held various roles in numerous public companies over the last 9 years and has previously provided corporate advisory services to listed and unlisted companies, focusing on restructuring and refinancing.
    Mr Zlatko (Zack) Bozinovski Chief Strategy OfficerExecutive Director Jul 2021
    Mr Bozinovski is an executive in the Australian retail industry with over 35 years' experience within FMCG and Pharmaceuticals companies in Australia and internationally. Mr Bozinovski co-founded Voost and has previously held senior positions at Uncle Tobys/Goodman Fielder, Pepsi Co and Sigma Pharmaceuticals.
    Mr Andrew Vidler Non-Executive Director Jan 2024
    Mr Vidler has experience across retail, consumer health products and retail pharmacy. Andrews 30 years experience includes approximately 20 years with the EBOS Group (formerly FH Faulding, Mayne Group and Symbion), where, across several roles, he led the Terry White Chemists and Chemmart pharmacy brands and the Endeavour Consumer Health products business. Mr Vidler is currently Pacific Smiles Group (PSQ:ASX) Managing Director and Chief Executive Officer. Aside from this role, Mr Vidler has no other ASX director roles. For the last four years Mr Vidler worked for API Limited (now Wesfarmers Health) where he was responsible for the Priceline retail and Priceline pharmacy businesses.
    Mr Jeffrey Yeh Non-Executive Director Jan 2024
    Mr Yeh has 21 years experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management. Mr Yeh co-founded Homart Pharmaceuticals (Homart) in 2002. Mr Yeh currently has no other ASX director roles.
    Mr Mario Tascone Non-Executive ChairmanNon-Executive Director Jan 2024
    Mr Tascone serving as Director of Sales and Marketing for Australias leading pharmacy retailer, Chemist Warehouse. Mr Tascone currently has no other ASX director roles.
    Mr Zheng (Kobe) Li Company Secretary Jan 2019
    -
    Zheng (Kobe) Li Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Ggp Investments Pty Ltd (Ggp Superannuation Fund A/C) 32,732,760 7.73%
    Kirby Superannuation Pty Ltd (Kirby Super Fund A/C) 25,333,332 5.98%
    Cw Retail Holdings Pty Ltd (Cw Retails Holdings A/C) 18,869,792 4.45%
    Wattle Trading Pty Ltd 18,831,453 4.44%
    Monex Boom Securities (Hk) Ltd (Clients Account) 17,750,302 4.19%
    Jysf Management Pty Ltd (Jysf A/C) 16,515,152 3.90%
    Zlj Pty Ltd (The Bozinovski Family A/C) 13,750,000 3.25%
    Simish Cosmetics Pty Ltd 13,500,000 3.19%
    Finclear Pty Ltd (Superhero Securities A/C) 10,556,010 2.49%
    Mr Xuan Khoa Pham 10,300,000 2.43%
    Eurofit S A Limited 10,138,902 2.39%
    Brilliant River Limited 7,211,301 1.70%
    Mr Andrew Grant 6,979,767 1.65%
    Homart Group Pty Ltd 6,818,182 1.61%
    Ggp Investments Pty Ltd (Ggp Superannuation Fund A/C) i 6,130,603 1.45%
    Jamata Pty Ltd + Llea Lk Pty Ltd (Lmb Wattle Trading Unit A/C) 5,894,370 1.39%
    Mr Keith William Bremner + Mrs Gabrielle Langner Bremner (Kega Superannuation A/C) 4,000,000 0.94%
    Hsbc Custody Nominees (Australia) Limited 3,574,624 0.84%
    Mr David James Stewart 2,966,667 0.70%
    Appwam Pty Ltd 2,400,000 0.57%

    Profile

    since

    Note